Mitochondria and Mustard Damage at the Ocular Surface
Mitochondria and Mustard Damage at the Ocular Surface
批准号:
10708498
负责人:
M. Elizabeth Fini
金额:
$53.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2026-08-31
关键词:
AbbreviationsAlkylationAttenuatedBioenergeticsCell Culture TechniquesCellsChemical WarfareChloroquineChronicComplexConsumptionCorneaCysteineCytoprotectionDataDevelopmentDimensionsDoxycyclineDynaminElectron TransportEnsureEpithelial CellsEpitheliumExposure toEyeFollow-Up StudiesGene Expression ProfileGenesHomeostasisHumanHydrogen PeroxideImageIn VitroKnowledgeMechlorethamineMedicalMethodsMitochondriaModelingMolecularMusMustardMustard CompoundsMustard GasNamesNomenclatureOxidative StressOxidative Stress InductionPathologicPathologyPathway interactionsPhasePhenotypePlayProductionProtein FamilyProteinsPublic HealthReactive Oxygen SpeciesReporterReporter GenesReportingRouteStressTechniquesTissuesToxic effectToxicant exposureTransgenic OrganismsValidationVesicantsanalogcell injurychemical disasterchemical threatcorneal epitheliumeye drynessin vivoinhibitorinnovationinsightlimbalmedical countermeasuremitochondrial permeability transition poremouse modelnovelocular surfacepreventresponseresponse to injurysingle-cell RNA sequencingsmall moleculesmall molecule inhibitorsynergismtert-Butylhydroperoxidetherapeutic targettranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Ocular surface (OcS) exposure to the chemical warfare vesicant sulfur mustard (SM), or its analogue nitrogen
mustard (NM), causes immediate tissue damage and long-term pathology. Current medical countermeasures
(MCMs) frequently result in incomplete or transient efficacy. Excessive accumulation of reactive oxygen
species (ROS) induces oxidative stress (OXS), which plays prominently in OcS epithelial damage from a
variety of causes, including exposure to SM and analogues. ROS are produced by mitochondria. It is known
that mitochondria are damaged by exposure to SM analogues, but mechanisms leading to OXS are under-
explored. Recently, the project team made the unexpected discovery that dynasore and dyngo-4a, small
molecules that target dynamin family proteins involved in mitochondrial homeostasis, are remarkably protective
against OXS due to hydrogen peroxide (HP) exposure in an OcS epithelial cell culture model. In a follow-up
study, they identified a novel pathway whereby dynasore protects by inhibiting Ca2+ influx, shifting activity of
the unfolded protein response (UPR) towards homeostasis and inhibiting mitochondrial transition pore (mPTP)
opening. In Preliminary Data presented herein, they now show that NM exposure also induces the UPR in the
cell culture model, but dynasore is not protective. Interestingly, another small molecule inhibitor of dynamins is
protective: mdivi-1. Signficantly, mdivi-1 did not shift the UPR towards homeostasis in NM-exposed cells and
did not protect against HP exposure. These results indicate that mechanisms leading to OXS after exposure to
HP or NM must be different, and that elucidating the mechanism of mDivi-1 counteraction may provide
important insight into how NM damages cells. Mdivi-1 has been widely considered to be a specific inhibitor of
the mitochondrial-localized dynamin DRP1. However, it was recently reported that mdivi-1 also directly targets
mitochondrial energetics. The objective of this project is to investigate mitochondrial mechanisms in
OcS exposure to NM, the relationship to HP exposure, and mechanisms of OcS protection by mdivi-1.
The team will employ a well-established human corneal epithelial cell culture model. To ensure scientific rigor,
primary human corneal epithelial cells will be used to validate key results in vitro, and a mouse model will
provide in vivo validation. To add an innovative dimension, live cell evaluative methods and discovery
techniques will be applied, including Ca2+ imaging, mitochondrial imaging, cell-based reporter constructs,
transgenic reporter mice, RNA-seq and single cell RNA-seq (scRNA-seq). Results of the planned study will
provide new knowledge about how NM exposure leads to OXS. Mdivi-1 has the unusual capacity to attenuate
pathological ROS production while having limited impact on ROS in healthy cells, making it uniquely attractive
as a potential MCM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynasore Analogues for Ocular Surface Protection
-
批准号:10310762
-
项目类别:
-
资助金额:$10.87万
-
财政年份:2019
-
负责人:M. Elizabeth Fini
-
依托单位:
Dynasore Analogues for Ocular Surface Protection
-
批准号:10004039
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2019
-
负责人:M. Elizabeth Fini
-
依托单位:
Protection and Treatment of the Ocular Surface Barrier
-
批准号:9334035
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Discovery Approach to Ocular Hypertension
-
批准号:9921393
-
项目类别:
-
资助金额:$59.29万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Discovery Approach to Ocular Hypertension
-
批准号:9333672
-
项目类别:
-
资助金额:$59.65万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Discovery Approach to Ocular Hypertension
-
批准号:9751867
-
项目类别:
-
资助金额:$59.29万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Clusterin at the Ocular Surface
-
批准号:9329433
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2016
-
负责人:M. Elizabeth Fini
-
依托单位:
Clusterin at the Ocular Surface
-
批准号:9196261
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2016
-
负责人:M. Elizabeth Fini
-
依托单位:
Clusterin at the Ocular Surface
-
批准号:9755442
-
项目类别:
-
资助金额:$55.67万
-
财政年份:2016
-
负责人:M. Elizabeth Fini
-
依托单位:
Miami Center for Vision Research
-
批准号:6888034
-
项目类别:
-
资助金额:$58.36万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
CORE--EQUIPMENT
-
批准号:6985840
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
AFMINISTRATION
-
批准号:6985838
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
Miami Center for Vision Research
-
批准号:6797085
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
Miami Center for Vision Research
-
批准号:7061202
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
Supplement to Core Grant for Vision Research
-
批准号:6494562
-
项目类别:
-
资助金额:$51.14万
-
财政年份:2002
-
负责人:M. Elizabeth Fini
-
依托单位:
Core Grant for Vision Research
-
批准号:6346517
-
项目类别:
-
资助金额:$39.97万
-
财政年份:2001
-
负责人:M. Elizabeth Fini
-
依托单位:
METALLOPROTEINASES AND FAILURE TO RE-EPITHELIALIZE
-
批准号:2082550
-
项目类别:
-
资助金额:$18.71万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
METALLOPROTEINASES AND FAILURE TO RE-EPITHELIALIZE
-
批准号:2082549
-
项目类别:
-
资助金额:$19.16万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
Maintenance of Ocular Surface Integrity
-
批准号:6686925
-
项目类别:
-
资助金额:$30.3万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
Maintenance of Ocular Surface Integrity
-
批准号:6927205
-
项目类别:
-
资助金额:$43.28万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
海外基金